• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NOVOCURE LTD NOVOTTF-100A

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NOVOCURE LTD NOVOTTF-100A Back to Search Results
Model Number TFH-9000
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Death (1802)
Event Date 10/23/2013
Event Type  Death  
Event Description
Patient with recurrent glioblastoma started novottf therapy on (b)(6) 2013.Novocure was informed that the patient died.Date of death was (b)(6) 2013.Per nurse at the prescribing site, cause of death was gbm progression, not related to novottf therapy.Patient had a rapidly progressing disease and died in hospice so no hospital summary was available.No adverse events associated with device use were reported.The last date of novottf therapy was not known until the equipment was returned to novocure and logfiles downloaded on (b)(6) 2013.Per logfile review, last device use was (b)(6) 2013, at 15:34 and device was functioning as per normal operating conditions.
 
Manufacturer Narrative
Novocure concurs with nurse at the prescribing site that death was related to glioblastoma.Death was not related to notify therapy.Death is an expected event in patients with recurrent glioblastoma due to the natural history of the disease.On the pivotal phase iii trail overall survival was 6.3/6.4 months in the novottf therapy and chemotherapy arm respectively.This event will be reported to the fda as per novocures standard operating procedures which state that any death that occurs within 24 hours of device use be reported (patient was wearing device on day of death).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NOVOTTF-100A
Manufacturer (Section D)
NOVOCURE LTD
haifa
IS 
Manufacturer Contact
eilon kirson
topaz bldg, shaar hacarmel
4th floor
haifa 31905
IS   31905
8501204
MDR Report Key3590979
MDR Text Key4162854
Report Number3009453079-2014-00035
Device Sequence Number1
Product Code NZK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100034
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Nurse
Type of Report Initial
Report Date 12/19/2013
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberTFH-9000
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer12/19/2013
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/19/2013
Initial Date FDA Received01/13/2014
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/01/2013
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age47 YR
Patient Weight132
-
-